Motus GI prices IPO at $5, the low end of the range
Motus GI Holdings, which is developing a medical device to assist with intraprocedural colonoscopy cleaning, raised $18 million by offering 3.5 million shares at $5, the low end of the range of $5 to $7. At pricing, the company commands a fully diluted market value of $79 million. Existing shareholders purchased $7.5 million (43% of deal size) on the IPO. Motus GI Holdings plans to list on the Nasdaq under the symbol MOTS. Piper Jaffray and Oppenheimer & Co. acted as lead managers on the deal.
The article Motus GI prices IPO at $5, the low end of the range originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.